702 related articles for article (PubMed ID: 16012126)
1. Development of the allocation system for deceased donor liver transplantation.
Coombes JM; Trotter JF
Clin Med Res; 2005 May; 3(2):87-92. PubMed ID: 16012126
[TBL] [Abstract][Full Text] [Related]
2. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
Trotter JF; Osgood MJ
JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for hepatocellular carcinoma: the MELD impact.
Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
[TBL] [Abstract][Full Text] [Related]
4. Quantifying Sex-Based Disparities in Liver Allocation.
Locke JE; Shelton BA; Olthoff KM; Pomfret EA; Forde KA; Sawinski D; Gray M; Ascher NL
JAMA Surg; 2020 Jul; 155(7):e201129. PubMed ID: 32432699
[TBL] [Abstract][Full Text] [Related]
5. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation in the MELD era: a single-center experience.
Sachdev M; Hernandez JL; Sharma P; Douglas DD; Byrne T; Harrison ME; Mulligan D; Moss A; Reddy K; Vargas HE; Rakela J; Balan V
Dig Dis Sci; 2006 Jun; 51(6):1070-8. PubMed ID: 16865573
[TBL] [Abstract][Full Text] [Related]
7. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
Sharma P; Schaubel DE; Messersmith EE; Guidinger MK; Merion RM
Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903
[TBL] [Abstract][Full Text] [Related]
8. Waiting list mortality for pediatric deceased donor liver transplantation in a Japanese living-donor-dominant program.
Kasahara M; Katono M; Schlegel A; Kubota T; Nakazato Y; Uchida H; Shimizu S; Yanagi Y; Takeda M; Fukuda A; Sakamoto S
Pediatr Transplant; 2019 Dec; 23(8):e13578. PubMed ID: 31535772
[TBL] [Abstract][Full Text] [Related]
9. Geographic Disparity in Deceased Donor Liver Transplant Rates Following Share 35.
Bowring MG; Zhou S; Chow EKH; Massie AB; Segev DL; Gentry SE
Transplantation; 2019 Oct; 103(10):2113-2120. PubMed ID: 30801545
[TBL] [Abstract][Full Text] [Related]
10. The history of organ donation and transplantation in Iran.
Ghods AJ
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():38-41. PubMed ID: 24635790
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy.
Wiesner RH; Freeman RB; Mulligan DC
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S261-7. PubMed ID: 15508092
[TBL] [Abstract][Full Text] [Related]
12. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
[TBL] [Abstract][Full Text] [Related]
13. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
14. Results of the first year of the new liver allocation plan.
Freeman RB; Wiesner RH; Edwards E; Harper A; Merion R; Wolfe R;
Liver Transpl; 2004 Jan; 10(1):7-15. PubMed ID: 14755772
[TBL] [Abstract][Full Text] [Related]
15. Sex Disparity in Liver Transplant and Access to Living Donation.
Karnam RS; Chen S; Xu W; Chen C; Elangainesan P; Ghanekar A; McGilvray I; Reichman T; Sayed B; Selzner M; Sapisochin G; Galvin Z; Hirschfield G; Asrani SK; Selzner N; Cattral M; Lilly L; Bhat M
JAMA Surg; 2021 Nov; 156(11):1010-1017. PubMed ID: 34406347
[TBL] [Abstract][Full Text] [Related]
16. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
[TBL] [Abstract][Full Text] [Related]
17. Reassessing the survival benefit of deceased donor liver transplantation: retrospective cohort study.
Malamon JS; Kaplan B; Jackson WE; Saben JL; Schold JD; Pomfret EA; Pomposelli JJ
Int J Surg; 2023 Sep; 109(9):2714-2720. PubMed ID: 37226874
[TBL] [Abstract][Full Text] [Related]
18. Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation.
Sharma P; Harper AM; Hernandez JL; Heffron T; Mulligan DC; Wiesner RH; Balan V
Am J Transplant; 2006 Aug; 6(8):1957-62. PubMed ID: 16771808
[TBL] [Abstract][Full Text] [Related]
19. Differences in access to liver transplantation: disease severity, waiting time, and transplantation center volume.
Ahmad J; Bryce CL; Cacciarelli T; Roberts MS
Ann Intern Med; 2007 May; 146(10):707-13. PubMed ID: 17502631
[TBL] [Abstract][Full Text] [Related]
20. Impact of MELD score implementation on liver allocation: experience at a Brazilian center.
da Silva Machado AG; de Medeiros Fleck A; Marroni C; Zanotelli ML; Cantisani G; de Mello Brandão AB
Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
